Clinical Trial Application approved by European authority to initiate Phase 2 study of JM-010 Posted on 22. October 2018
Bukwang registered patents on a therapeutic candidate for Levodopa-induced dyskinesia in Parkinson’s disease Posted on 31. January 2018
US patent covering JM-010 for treatment of movement disorders has been granted Posted on 6. November 2015
Solural Pharma and Contera Pharma initiate Eurostar sponsored project in Parkinson’s disease Posted on 1. May 2015